Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This refers to a combination kit or package containing both **cyanocobalamin** (a synthetic form of vitamin B12, used to treat or prevent deficiency) and **isopropyl alcohol** (commonly as an antiseptic pad or swab), typically provided together for the administration of vitamin B12 injections. Cyanocobalamin acts as a cofactor in many enzymatic reactions needed for DNA synthesis and cellular energy production. Isopropyl alcohol acts as a topical antiseptic, used to clean the skin prior to injection to prevent infection. No evidence suggests a unique pharmacological effect for their combination, as isopropyl alcohol is not administered systemically, but used externally for asepsis. Such kits are mainly for convenience and compliance in outpatient self-injection or in clinical settings[3][1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyanocobalamin + isopropyl alcohol.